NOVARTIS AG (NVS) Executive Compensation
NOVARTIS AG (NVS) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NVS
CIK: 1114448
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: V8
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG AG
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerMalcolm Dahn
Audit LocationBasel, Switzerland
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-09-08 | 2026-09-08 | FORM 6-K | 0001171843-26-005908 | View SEC Doc Filr Page |
| 6-K | 2026-09-04 | 2026-09-04 | FORM 6-K | 0001171843-26-005896 | View SEC Doc Filr Page |
| 6-K | 2026-09-01 | 2026-09-01 | FORM 6-K | 0001171843-26-005824 | View SEC Doc Filr Page |
| 6-K | 2026-07-21 | 2026-06-30 | 6-K | 0001114448-26-000012 | View SEC Doc Filr Page |
| 6-K | 2026-06-11 | 2026-06-11 | FORM 6-K | 0001171843-26-004052 | View SEC Doc Filr Page |
| 144 | 2026-04-30 | — | 144 Filing | 0001959173-26-003145 | View SEC Doc Filr Page |
| 6-K | 2026-04-28 | 2026-03-31 | 6-K | 0001114448-26-000010 | View SEC Doc Filr Page |
| 6-K | 2026-03-18 | 2026-03-18 | FORM 6-K | 0001104659-26-031037 | View SEC Doc Filr Page |
| 424B5 | 2026-03-17 | — | 424B5 | 0001104659-26-029551 | View SEC Doc Filr Page |
| FWP | 2026-03-17 | — | FWP | 0001104659-26-028701 | View SEC Doc Filr Page |
| 424B5 | 2026-03-16 | — | 424B5 | 0001104659-26-028048 | View SEC Doc Filr Page |
| 144 | 2026-02-12 | — | 144 Filing | 0001959173-26-000921 | View SEC Doc Filr Page |
| 144 | 2026-02-09 | — | 144 Filing | 0001959173-26-000748 | View SEC Doc Filr Page |
| S-8 | 2026-02-04 | — | FORM S-8 | 0001104659-26-010334 | View SEC Doc Filr Page |
| 6-K | 2026-02-04 | 2025-12-31 | 6-K | 0001114448-26-000008 | View SEC Doc Filr Page |
| 6-K | 2026-02-04 | 2025-12-31 | 6-K | 0001114448-26-000007 | View SEC Doc Filr Page |
| IRANNOTICE | 2026-02-04 | — | IRANNOTICE Filing | 0001114448-26-000006 | View SEC Doc Filr Page |
| 20-F | 2026-02-04 | 2025-12-31 | 20-F | 0001114448-26-000004 | View SEC Doc Filr Page |
| S-8 POS | 2026-01-16 | — | S-8 POS | 0001104659-26-004593 | View SEC Doc Filr Page |
| S-8 POS | 2026-01-16 | — | S-8 POS | 0001104659-26-004592 | View SEC Doc Filr Page |
| S-8 POS | 2026-01-16 | — | S-8 POS | 0001104659-26-004591 | View SEC Doc Filr Page |
| S-8 POS | 2026-01-16 | — | S-8 POS | 0001104659-26-004590 | View SEC Doc Filr Page |
| DFAN14A | 2026-01-14 | — | DFAN14A | 0001104659-26-003727 | View SEC Doc Filr Page |
| DFAN14A | 2026-01-12 | — | DFAN14A | 0001104659-26-002891 | View SEC Doc Filr Page |
| 6-K | 2025-11-25 | 2025-11-24 | FORM 6-K | 0001171843-25-007547 | View SEC Doc Filr Page |